Class I Graft-Versus-Host Mismatch Based on Predicted Indirectly Recognizable HLA Epitopes (PIRCHES) Is Associated with Worse Post-Transplant Outcomes in Patients Receiving Peripheral Blood, T-Cell Replete Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide

被引：0
作者：
Rimando, Joseph [1 ]
Slade, Michael [2 ]
Gao, Feng [3 ]
Romee, Rizwan [4 ,5 ]
Liu, Chang [6 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO USA
[2] Washington Univ, Sch Med, Div Oncol, Bone Marrow Transplantat & Leukemia Sect, St Louis, MO USA
[3] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth,Sci Sect Oncol Biostat, St Louis, MO 63110 USA
[4] Dana Farber Canc Inst, Dept Hematol Malignancies, Boston, MA 02115 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Washington Univ, Sch Med, Pathol & Immunol, St Louis, MO USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
289
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Favorable Immune Reconstitution After Nonmyeloablative, T-Cell Replete, HLA-Haploidentical BMT with Post-Transplant Cyclophosphamide
    Symons, Heather J.
    Kesserwan, Chimene
    Kos, Ferdynand
    Thoburn, Christopher J.
    Munchel, Ashley T.
    Ying, Wendy
    Luznik, Leo
    Levitsky, Hyam I.
    Jones, Richard J.
    Hess, Allan D.
    Fuchs, Ephraim J.
    BLOOD, 2011, 118 (21) : 461 - 462
  • [32] Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies
    Tzu-Ting Chen
    Ching-Chan Lin
    Wen-Jyi Lo
    Ching-Yun Hsieh
    Ming-Yu Lien
    Che-Hung Lin
    Chen-Yuan Lin
    Li-Yuan Bai
    Chang-Fang Chiu
    Su-Peng Yeh
    International Journal of Hematology, 2022, 115 : 525 - 533
  • [33] Post-Transplant Cyclophosphamide, Abatacept and Short Course of Tacrolimus (CAST) for Graft-Versus-Host Disease Prevention Following Haploidentical Peripheral Blood Stem Cell Transplantation
    Al-Homsi, A. Samer
    Cirrone, Frank
    Cole, Kelli
    Suarez-Londono, Jaime Andres
    Gardner, Sharon L.
    Hsu, Jingmei
    Wo, Stephanie
    Stocker, Kelsey
    Bruno, Benedetto
    Goldberg, Judith
    Levinson, Benjamin
    Abdul-Hay, Maher
    BLOOD, 2022, 140 : 7628 - 7630
  • [34] Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies
    Chen, Tzu-Ting
    Lin, Ching-Chan
    Lo, Wen-Jyi
    Hsieh, Ching-Yun
    Lien, Ming-Yu
    Lin, Che-Hung
    Lin, Chen-Yuan
    Bai, Li-Yuan
    Chiu, Chang-Fang
    Yeh, Su-Peng
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 525 - 533
  • [35] Class II HLA Fipitope Level Mismatch Can Predict Chronic Graft-Versus-Host Disease and Survival Following Haploidentical Transplant Using Post-Transplant Cyclophosphamide
    Solomon, Scott R.
    Aubrey, Michael T.
    Anobile, Cheri
    Zhang, Xu
    Freed, Brian M.
    Morris, Lawrence E.
    Holland, H. Kent
    Solh, Melhem
    Bashey, Asad
    BLOOD, 2018, 132
  • [36] Achievement of High Concentration of Cyclosporine-a Is Associated with a Low Incidence of Acute Graft-Versus-Host Disease after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Graft
    Stocker, Nicolas
    Dulery, Remy
    Mediavilla, Clemence
    Brissot, Eolia
    Battipaglia, Giorgia
    Sestili, Simona
    Ruggeri, Annalisa
    Mohty, Razan
    Mohty, Mohamad
    Malard, Florent
    BLOOD, 2018, 132
  • [37] POST-TRANSPLANT CYCLOPHOSPHAMIDE AS GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN HLA-IDENTICAL SIBLING HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Bailen, Rebeca
    Kwon, Mi
    Pascual Cascon, Maria Jesus
    Balsalobre, Pascual
    Diaz Aizpun, Carlota
    Benitez Hidalgo, Olga
    Serrano, David
    Anguita, Javier
    Buno, Ismael
    Dorado, Nieves
    Solan, Laura
    Luis Diez-Martin, Jose
    BONE MARROW TRANSPLANTATION, 2018, 53 : 437 - 438
  • [38] Graft-Versus-Host Disease Prophylaxis with Post-Transplant Cyclophosphamide Better Preserves Regulatory T Cell
    Koh, Jeong Suk
    Heo, Buyeon
    Lee, Seul Bi
    Choi, Su-Young
    Pham, Thi Thuy Duong
    Lee, Sang-Woo
    Park, Jung-Hyun
    Jang, Yunseon
    Seo, Wonhyoung
    Lee, Myung-Won
    Jo, Deog-Yeon
    Kwon, Jaeyul
    Song, Ik Chan
    BLOOD, 2024, 144 : 7371 - 7371
  • [39] Dynamics and Predictive Value of T-Cell Chimerism after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
    Wang, Jiasheng
    Tomlinson, Benjamin
    Malek, Ehsan
    Metheny, Leland
    Gallogly, Molly
    de Lima, Marcos
    Kolk, Merle
    Cooper, Brenda W.
    BLOOD, 2022, 140 : 12831 - 12832
  • [40] Post-transplant cyclophosphamide, abatacept, and short course of tacrolimus (cast) for graft-versus-host disease prevention following haploidentical hematopoietic stem cell transplantation
    Al-Homsi, A. S.
    Cirrone, F.
    Cole, K.
    Stocker, K.
    Bruno, B.
    Suarez-Londono, J. A.
    Gardner, S.
    Goldberg, J.
    Hay, M. Abdul
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 198 - 199
12345